Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent
Clinical trial NCT05230940 · COMPLETED
Trial details
- NCT number
- NCT05230940
- Sponsor
- Health Institutes of Turkey
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-18
- Primary completion
- 2023-05-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.